Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. - Hanna,N.; Bunn Jr.,P.A.; Langer,C. (J Clin Oncol, 2006)